Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race.

Source:http://linkedlifedata.com/resource/pubmed/id/12809452

Ann. Intern. Med. 2003 Jun 17 138 12 960-8

Download in:

View as

Triples

General Info

PMID
12809452